# US 2023/0411012 A1 · Method and diagnostic apparatus for determining obesity using machine learning model

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0411012 A1
- Document ID: US20230411012A1
- Status: Published application
- Kind: A1
- Application number: 18/459,463
- Filed: 2023-09-01
- Published: 2023-12-21
- Earliest claimed: 2021-03-21
- Assignees: Hem Pharma Inc.
- Applicants: Hem Pharma Inc.
- Inventors: Yo Sep JI; So Young PARK
- Web page: https://patentgrep.com/patent/US20230411012A1

## CPC

- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- C12Q 1/6869: Methods for sequencing
- G01N 33/56911: {Bacteria}
- G16B 40/20: Supervised data analysis
- G16C 20/10: Analysis or design of chemical reactions, syntheses or processes
- G16C 20/70: Machine learning, data mining or chemometrics
- G16C 20/90: Programming languages; Computing architectures; Database systems; Data warehousing
- G16H 40/67: for remote operation
- G16H 50/30: for calculating health indices; for individual health risk assessment
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16C: COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE

## Abstract

A method for determining whether obesity is present by using a machine learning model may include a process of analyzing a mixture of a gut-derived substance collected from a subject and a gut environment-like composition, a process of extracting multiple microbial data based on an analysis result of the mixture, a process of selecting microbe-related features to be used in the machine learning model from the multiple microbial data based on a predetermined feature selection algorithm, a process of training the machine learning model with the microbe-related features, and a process of inputting, to the trained machine learning model, the microbial data collected from the subject to be tested and determining whether obesity is present. The microbe-related features may include the amount of one or more microbes selected from families included in orders, Lachnospirales, Lactobacillales, and Erysipelotrichales.

## Claims

### Claim 1

A method for diagnosing the presence or absence of obesity by using a machine learning model, comprising:
a process of analyzing a mixture of a gut-derived substance collected from a subject and a gut environment-like composition;
a process of extracting multiple microbial data based on an analysis result of the mixture;
a process of selecting microbe-related features to be used in the machine learning model from the multiple microbial data based on a Boruta algorithm or a recursive feature elimination (RFE) algorithm;
a process of training the machine learning model with the microbe-related features to predict whether obesity is present for each of the microbial data; and
a process of inputting, to the trained machine learning model, the microbial data extracted based on the analysis result of the mixture of the gut-derived substance collected from the subject to be tested and the gut environment-like composition and determining whether obesity is present based on an output value of the machine learning model,
wherein the microbe-related features include the amount of one or more microbes selected from families included in orders, Lachnospirales, Lactobacillales, and Erysipelotrichales.

### Claim 2 (depends on 1)

The method for diagnosing the presence or absence of obesity of claim 1,
wherein the process of analyzing a mixture includes:
a process of culturing the mixture for 18 to 24 hours under anaerobic conditions; and
a process of analyzing a culture in which the mixture has been cultured.

### Claim 3 (depends on 2)

The method for diagnosing the presence or absence of obesity of claim 2,
wherein the process of analyzing a culture includes:
a process of centrifuging the culture to separate a supernatant and a precipitate and analyzing the supernatant and the precipitate.

### Claim 4 (depends on 2)

The method for diagnosing the presence or absence of obesity of claim 2,
wherein the microbial data include at least one of the amount, concentration, and kind of one or more of endotoxins, hydrogen sulfides, short-chain fatty acids (SCFAs) and microbiota-derived metabolites contained in the culture, and a change in kind, concentration, amount or diversity of bacteria included in the microbiota.

### Claim 5 (depends on 1)

The method for diagnosing the presence or absence of obesity of claim 1,
wherein the machine learning model includes at least one of a logistic regression model, a generalized linear (GLM) model, a random forest model, a gradient boosting model, and an extreme gradient boosting (XGB) model.

### Claim 6 (depends on 1)

The method for diagnosing the presence or absence of obesity of claim 1,
wherein the microbe-related features include the amount of one or more microbes selected from genera included in families, Lachnospiraceae, Leuconostocaceae, and Erysipelotrichaeae.

### Claim 7 (depends on 1)

The method for diagnosing the presence or absence of obesity of claim 1,
wherein the microbe-related features include the amount of one or more microbes selected from species included in genera, Blautia, Holdemania, Coprococcus, and Ruminococcus.

### Claim 8

An apparatus for diagnosing obesity by using a machine learning model, comprising:
a microbial data extraction unit that extracts multiple microbial data based on an analysis result of a mixture of a gut-derived substance collected from a subject and a gut environment-like composition;
a feature selection unit that selects microbe-related features to be used in the machine learning model from the multiple microbial data based on a Boruta algorithm or a recursive feature elimination (RFE) algorithm;
a training unit that trains the machine learning model with the microbe-related features to predict whether obesity is present for each of the microbial data; and
a diagnosis unit that inputs, to the trained machine learning model, the microbial data extracted based on the analysis result of the mixture of the gut-derived substance collected from the subject to be tested and the gut environment-like composition and diagnoses obesity based on whether obesity is present, which is an output value of the machine learning model,
wherein the microbe-related features include the amount of one or more microbes selected from families included in orders, Lachnospirales, Lactobacillales, and Erysipelotrichales.

### Claim 9 (depends on 8)

The apparatus for diagnosing obesity of claim 8,
wherein the microbial data include at least one of the amount, concentration and kind of one or more of endotoxins, hydrogen sulfides, short-chain fatty acids (SCFAs) and microbiota-derived metabolites contained in a culture in which the mixture has been cultured 18 to 24 hours under anaerobic conditions, and a change in kind, concentration, amount or diversity of bacteria included in the microbiota.

### Claim 10 (depends on 8)

The apparatus for diagnosing obesity of claim 8,
wherein the machine learning model includes at least one of a logistic regression model, a generalized linear (GLM) model, a random forest model, a gradient boosting model, and an extreme gradient boosting (XGB) model.

### Claim 11 (depends on 8)

The apparatus for diagnosing obesity of claim 8,
wherein the microbe-related features include the amount of one or more microbes selected from genera included in families, Lachnospiraceae, Leuconostocaceae, and Erysipelotrichaeae.

### Claim 12 (depends on 8)

The apparatus for diagnosing obesity of claim 8,
wherein the microbe-related features include the amount of one or more microbes selected from species included in genera, Blautia, Holdemania, Coprococcus, and Ruminococcus.
